Cargando…

Safety and efficacy of herbal extracts to restore respiratory health and improve innate immunity in COVID-19 positive patients with mild to moderate severity: A structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: Primary Objective • To assess the efficacy of herbal extracts in boosting innate immunity of patients with COVID-19 infection. Secondary Objectives • To assess the efficacy of herbal extracts in restoring respiratory health • To assess the efficacy of Cap. IP in early recovery of patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rangnekar, Hrishikesh, Patankar, Suresh, Suryawanshi, Kishor, Soni, Pravin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680979/ https://www.ncbi.nlm.nih.gov/pubmed/33225970 http://dx.doi.org/10.1186/s13063-020-04906-x

Ejemplares similares

Efficacy and safety of polyherbal formulation as an add-on to standard-of-care in mild-to-moderate COVID-19: A randomized, double-blind, placebo-controlled trial
por: Patankar, Suresh B., et al.
Publicado: (2022)

A randomized controlled pilot study of add-on therapy of CIM-MEG19 (standardized Andrographis paniculata formulation) in mild to moderate COVID-19
por: Shanker, Karuna, et al.
Publicado: (2023)

Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial
por: Lawlor, Brian, et al.
Publicado: (2018)

Effectiveness of Chinese herbal medicine Ping Chuan Ke Li for the management of mild/moderate persistent asthma
por: Li, Zhu-Ying, et al.
Publicado: (2018)

Safety and efficacy of an herbal formulation in patients with renal calculi - A 28 week, randomized, double-blind, placebo-controlled, parallel group study
por: Patankar, Suresh B., et al.
Publicado: (2020)

Add-on effect of Chinese herbal medicine in the treatment of mild to moderate COVID-19: A systematic review and meta-analysis
por: Du, Xuqin, et al.
Publicado: (2021)

Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial
por: Vergis, Nikhil, et al.
Publicado: (2021)

Multi-Arm Trial of Inflammatory Signal Inhibitors (MATIS) for Hospitalised Patients with Mild or Moderate COVID-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomised Controlled Trial
por: Charania, Asad, et al.
Publicado: (2021)

A quadruple blinded placebo controlled randomised trial to evaluate the effectiveness of an Iodine complex for patients with mild to moderate COVID-19 in Pakistan (I-COVID-PK): A structured summary of a study protocol for a randomised controlled trial
por: Ashraf, Sohaib, et al.
Publicado: (2021)

The effect of herbal medicine in innate immunity to Candida albicans
por: Bao, Meng-Yuan, et al.
Publicado: (2023)

The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial
por: Hosseini, Fatemeh Sadat, et al.
Publicado: (2021)

Efficacy and Safety of Complementary Therapy With Jing Si Herbal Tea in Patients With Mild-To-Moderate COVID-19: A Prospective Cohort Study
por: Hsieh, Po-Chun, et al.
Publicado: (2022)

Effect of a Virtual Reality-Based Restorative Environment on the Emotional and Cognitive Recovery of Individuals with Mild-to-Moderate Anxiety and Depression
por: Li, Hongqidi, et al.
Publicado: (2021)

Randomised controlled trial of early frenotomy in breastfed infants with mild–moderate tongue-tie
por: Emond, Alan, et al.
Publicado: (2014)

Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD
por: Johnson, Kate M, et al.
Publicado: (2018)

Life review and life story books for people with mild to moderate dementia: a randomised controlled trial
por: Subramaniam, Ponnusamy, et al.
Publicado: (2013)

A proposed classification system for herbal endodontic irrigants
por: Kale, Purva Pravin, et al.
Publicado: (2021)

Chinese herbal medicine granules (PTQX) for children with moderate to severe atopic eczema: study protocol for a randomised controlled trial
por: Gu, Sherman X., et al.
Publicado: (2015)

Role of Dantabija, Haridra, and Zingiber (DHZ) combination to restore health and immunity in mild to moderate COVID-19 patients
por: Kumar, Yogesh, et al.
Publicado: (2022)

Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial
por: Koshak, Abdulrahman E., et al.
Publicado: (2020)

Effectiveness of balance training exercise in people with mild to moderate severity Alzheimer's disease: protocol for a randomised trial
por: Hill, Keith D, et al.
Publicado: (2009)

Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial
por: Piette, François, et al.
Publicado: (2011)

Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial
por: Rubin, David T., et al.
Publicado: (2017)

Clinical Assessment of the Hyperbaric Oxygen Therapy Efficacy in Mild to Moderate Periodontal Affections: A Simple Randomised Trial
por: Burcea, Alexandru, et al.
Publicado: (2022)

Ventricular conduction abnormality in patients with mild to moderate cardiomyopathy
por: Dhande, Mehak, et al.
Publicado: (2023)

Chinese Herbal Medicine (Zi Shen Qing) for Mild-to-Moderate Systematic Lupus Erythematosus: A Pilot Prospective, Single-Blinded, Randomized Controlled Study
por: Zhong, Linda L. D., et al.
Publicado: (2013)

Mild cognitive impairment: historical development and summary of research
por: Golomb, James, et al.
Publicado: (2004)

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
por: Tang, Wei, et al.
Publicado: (2020)

Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial
por: Rubin, David T, et al.
Publicado: (2017)

Effects of rehabilitation training on an elderly population with mild to moderate hearing loss: study protocol for a randomised clinical trial
por: Rasouli Fard, Parisa, et al.
Publicado: (2020)

Moderate-to-vigorous group aerobic exercise versus group leisure activities for mild-to-moderate depression in adolescents: study protocol for a multicentre randomised controlled trial
por: Mortazavi, Rebecca, et al.
Publicado: (2022)

Efficacy and safety of chinese herbal medicine for treating mild or moderate COVID-19: A systematic review and meta-analysis of randomized controlled trials and observational studies
por: Zhu, Hongfei, et al.
Publicado: (2022)

The role of noninvasive ventilation in mild to moderate acute respiratory distress syndrome
por: Rao, Manimala S., et al.
Publicado: (2015)

A study on the role of noninvasive ventilation in mild-to-moderate acute respiratory distress syndrome
por: Sehgal, Inderpaul Singh, et al.
Publicado: (2015)

Why mild contrast medium-induced reactions are sometimes over-treated and moderate/severe reactions of internal organs are undertreated: a summary based on RadioComics
por: Lombardo, Paolo, et al.
Publicado: (2023)

Cytodiagnosis of isolated primary hydatid cyst of breast masquerading as a breast neoplasm: A rare case report
por: Mujawar, Parvej, et al.
Publicado: (2015)

BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial
por: Junqueira-Kipnis, Ana Paula, et al.
Publicado: (2020)

Do sociodemographic variables moderate effects of an internet intervention for mild to moderate depressive symptoms? An exploratory analysis of a randomised controlled trial (EVIDENT) including 1013 participants
por: Nolte, Sandra, et al.
Publicado: (2021)

Safety and efficacy of fluticasone/formoterol combination therapy in adolescent and adult patients with mild-to-moderate asthma: a randomised controlled trial
por: Nathan, Robert A, et al.
Publicado: (2012)

Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke (ATAMIS): a parallel, randomised, open-label, multicentre, prospective study
por: Hou, Xiaowen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_shb1setmvkumd8s8cjkdnb8vbo